Your browser doesn't support javascript.
loading
Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer.
Southcott, D; Awan, A; Ghate, K; Clemons, M; Fernandes, R.
Affiliation
  • Southcott D; Division of Medical Oncology, Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON.
  • Awan A; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa.
  • Ghate K; Department of Medicine, Division of Medical Oncology, Oakville Trafalgar Memorial Hospital, Oakville, ON.
  • Clemons M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa.
  • Fernandes R; Division of Medical Oncology, Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON.
Curr Oncol ; 27(4): 220-224, 2020 08.
Article in En | MEDLINE | ID: mdl-32905286
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Prostatic Neoplasms, Castration-Resistant Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Curr Oncol Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Prostatic Neoplasms, Castration-Resistant Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Curr Oncol Year: 2020 Document type: Article Country of publication: